CBAY | Cymabay Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Newark, California, United States Trade prices Volume: Market Cap: 234.56M Prev closed: Open: 3.04 High: 3.2 Low: 3.04 52 week low: 2.67 52 week high: 5.13 Dividends: No Dividends Next ER: May 11, 2023
Company Profile We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2023 March 16, 2023 -0.3 / -0.3- / 5MNovember 14, 2022 -0.28 / -0.3- / -August 11, 2022 -0.31 / -0.2988- / -May 12, 2022 -0.32 / -0.31- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 3.740 4.200 4.230
3.730
794.78K -10.1% Aug 10, 2022 4.160 4.150 4.235
4.009
363.46K 1.96% Aug 9, 2022 4.080 4.010 4.090
3.820
624.33K 1.24% Aug 8, 2022 4.030 4.250 4.300
4.020
801.34K -5.18% Aug 5, 2022 4.250 4.100 4.250
4.029
465.75K 3.16% Aug 4, 2022 4.120 4.000 4.200
3.930
924.80K 5.64% Aug 3, 2022 3.900 3.530 4.090
3.499
1.45M 12.07% Aug 2, 2022 3.480 3.200 3.500
3.185
1.38M 8.41% Aug 1, 2022 3.210 3.130 3.340
3.070
632.54K 2.56% Jul 29, 2022 3.130 3.180 3.185
3.080
230.37K -2.19% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q4 2022 Earnings Call Transcript finance.yahoo.com Mar 20, 2023 9:04 pm CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01 seekingalpha.com Mar 17, 2023 4:08 am
CymaBay Reports Fourth Quarter and Year Ended December 31, 2022 Financial Results and Provides Corporate Update finance.yahoo.com Mar 16, 2023 4:04 pm CymaBay Therapeutics Q4 2022 Earnings Preview seekingalpha.com Mar 16, 2023 5:35 am
CymaBay Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference finance.yahoo.com Mar 1, 2023 8:00 am
CymaBay Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters Option to Purchase Additional Shares finance.yahoo.com Jan 30, 2023 8:00 am CymaBay gains on pricing of $85.05M public offering seekingalpha.com Jan 24, 2023 8:37 pm CymaBay stock pops 7% after launching stock and warrants offering seekingalpha.com Jan 24, 2023 5:39 am
CymaBay Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants finance.yahoo.com Jan 23, 2023 4:11 pm CymaBay join hands with Kaken to develop, commercialize Seladelpar seekingalpha.com Jan 9, 2023 3:52 pm
CymaBay Therapeutics Announces Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis finance.yahoo.com Jan 8, 2023 12:00 pm
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? finance.yahoo.com Nov 17, 2022 9:40 am CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02 seekingalpha.com Nov 15, 2022 5:17 am CymaBay Therapeutics Inc. (CBAY) Q2 2022 Earnings Call Transcript fool.com Aug 12, 2022 4:30 am CymaBay Therapeutics Q3 2022 Earnings Preview seekingalpha.com Nov 14, 2022 6:35 am
CymaBay Therapeutics to Report Third Quarter of 2022 Financial Results on Monday, November 14, 2022 finance.yahoo.com Nov 7, 2022 4:05 pm
CymaBay Therapeutics to Present at Upcoming Investment Conferences finance.yahoo.com Nov 3, 2022 8:00 am
Institutional investors own a significant stake of 50% in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) finance.yahoo.com Oct 13, 2022 9:58 am
CymaBay Therapeutics Announces Three Presentations at The Liver MeetingĀ® 2022 finance.yahoo.com Oct 3, 2022 8:00 am
CymaBay Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com Sep 6, 2022 8:02 am This company doesn't provide a dividend.
Talk about Cymabay Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology